CTI is a leading full-service clinical research organization based in Cincinnati, OH, specializing in therapeutic areas such as development and strategy, clinical services, research center lifecycle support, and real-world evidence. With a recent acquisition of Clinart in the Middle East and Northern Africa, CTI has expanded its global reach to continue important work in COVID-19 research.
Recognized as the #1 CRO in the world for quality at the 2020 CRO Leadership Awards, CTI is dedicated to providing high-quality service to sponsors and partners. Through collaborations with organizations like Medidata, St. Elizabeth Healthcare, Pulmotect, and Humanigen, CTI is at the forefront of developing innovative treatments and solutions for COVID-19 and other infectious diseases.
Generated from the website